Search

Your search keyword '"Kondo, Yutaka"' showing total 1,922 results

Search Constraints

Start Over You searched for: Author "Kondo, Yutaka" Remove constraint Author: "Kondo, Yutaka"
1,922 results on '"Kondo, Yutaka"'

Search Results

153. Supplementary Materials and Methods from LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

154. Supplementary Figure 4 from Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

155. Data from LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

156. Supplementary Table 7 from Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

158. Supplemental Figure Legends from Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses

163. Supplementary Table 4 from Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

164. Supplementary Figure 1 from Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

165. Supplementary Figures 1-5 and Tables 1-5 from Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma

166. Supplementary Table 1 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis

167. Supplementary Figure 2 from Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma

170. Rapid detection of theMYD88 L265Pmutation for pre‐ and intra‐operative diagnosis of primary central nervous system lymphoma

173. Effects of non-invasive ventilation in patients with acute respiratory failure excluding post-extubation respiratory failure, cardiogenic pulmonary edema and exacerbation of COPD: a systematic review and meta-analysis

181. Heat stroke management during the COVID‐19 pandemic: Recommendations from the experts in Japan (2nd edition)

185. Effectiveness of early colonoscopy in patients with colonic diverticular hemorrhage: Nationwide inpatient analysis in Japan

186. CD79BY196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma

188. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma

191. BIOM-58. ROLE OF CD79B Y196 MUTATION IN PCNSL AS A POTENT PREDICTIVE MARKER FOR FAVORABLE RESPONSE TO R-MPV TREATMENT AND DEVELOPMENT OF RAPID ALL-IN-ONE GENOTYPING SYSTEM FOR MOLECULAR MARKERS OF PCNSL

Catalog

Books, media, physical & digital resources